Skip to content

Effect of NO Precursors on Physiological Responses to Exercise

The Effect of NO Precursors on Physiological Responses to Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02850367
Acronym
NO-SUP
Enrollment
63
Registered
2016-08-01
Start date
2016-05-09
Completion date
2021-09-30
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physiology

Brief summary

NO is an ubiquitous molecule contributing to many physiological functions such as vasodilation, immune and oxidative stress responses. NO production can be supplemented either by providing substrate to the NO-synthase (L-Arginine and L-Citruline) or by providing nitrate which can lead to NO. In the present project the investigators evaluate the effect of various acute and chronic oral NO precursors supplementation on exercise performance and responses in healthy young and older subjects.

Interventions

DIETARY_SUPPLEMENTNitrate

Subjects will be supplemented orally either acutely or chronically (4-8 weeks) with NO precursors.

DIETARY_SUPPLEMENTNitrate and L-Arginine

Subjects will be supplemented orally either acutely or chronically (4-8 weeks) with NO precursors.

DIETARY_SUPPLEMENTNitrate and L-Citrulline

Subjects will be supplemented orally either acutely or chronically (4-8 weeks) with NO precursors.

DIETARY_SUPPLEMENTPlacebo

Subjects will be supplemented orally either acutely or chronically (4-8 weeks) with a placebo.

BIOLOGICALEvaluation of post-ischemic vascular reactivity

After the intake of the supplement. Concentration of hemoglobin (g/mL) in the quadriceps with the device : NIRS system Oxymon, ARTINIS.

BIOLOGICALNeuromuscular evaluations

After the intake of the supplement. Measure the stretching force in the ankle (N)

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Sedentary subjects * No cardiovascular, respiratory, metabolic and neurological disorders

Exclusion criteria

* Body mass index \> 28 kg.m-2 * Smoker * Alcool intake \> 10g/day * Psychiatric diseases * Subjects under treatment able to interfere with their cardiovascular, metabolic and neurological status

Design outcomes

Primary

MeasureTime frameDescription
Neuromuscular evaluations3 half daysAfter the intake of the supplement. Measure the stretching force in the ankle (N)
Evaluation of post-ischemic vascular reactivity3 half daysAfter the intake of the supplement. Concentration of hemoglobin (g/mL) in the quadriceps with the device : NIRS system Oxymon, ARTINIS.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026